Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| iShares Core U.S. Aggregate Bo | 6,726,030 | 10,271,333 | +3,545,303 | $667.69M | $1.02B | 82.00% | +$348.96M |
| Vanguard S&P 500 ETF | 94,300 | 92,692 | -1,608 | $56.35M | $63.66M | 5.14% | +$7.31M |
| iShares Short Duration Bond Ac SHOR DURA BD ETF | 490,400 | 490,400 | 0 | $24.93M | $24.84M | 2.00% | -$85.8K |
| iShares Core S&P 500 ETF | 0 | 27,334 | +27,334 | $0 | $20.47M | 1.65% | +$20.47M |
| Vanguard Total International S | 242,510 | 221,656 | -20,854 | $18.70M | $18.95M | 1.53% | +$249.4K |
| Vanguard Short-Term Bond ETF | 143,018 | 217,799 | +74,781 | $11.21M | $16.97M | 1.37% | +$5.75M |
| Vanguard Total Bond Market ETF | 174,088 | 185,855 | +11,767 | $12.82M | $13.64M | 1.10% | +$823.8K |
| Vanguard Long-Term Corporate B LG-TERM COR BD | 176,839 | 180,653 | +3,814 | $13.21M | $13.59M | 1.10% | +$380.7K |
| Vanguard Intermediate-Term Cor INT-TERM CORP | 160,545 | 162,657 | +2,112 | $13.29M | $13.44M | 1.08% | +$158.5K |
| Vanguard Short-Term Corporate SHRT TRM CORP BD | 168,364 | 170,023 | +1,659 | $13.35M | $13.44M | 1.08% | +$90.7K |
| Vanguard Extended Market ETF | 50,963 | 48,761 | -2,202 | $10.49M | $12.01M | 0.97% | +$1.52M |
| iShares S&P 500 Growth ETF | 39,275 | 52,602 | +13,327 | $4.44M | $7.23M | 0.58% | +$2.79M |
| iShares TIPS Bond ETF | 33,485 | 37,288 | +3,803 | $3.70M | $4.08M | 0.33% | +$385.0K |
| iShares S&P 500 Value ETF | 757 | 2,373 | +1,616 | $159.8K | $538.8K | 0.04% | +$379.0K |
| Rani Therapeutics Holdings, Inc.(RANI) | 302,743 | 302,743 | 0 | $222.5K | $230.2K | 0.02% | +$7.8K |